Glenn Dranoff, M.D.
Dana-Farber Cancer Institute, Harvard Medical School
Dr. Dranoff received his BS from Duke University and his MD from Duke University School of Medicine. He completed an internship and residency in internal medicine at Massachusetts General Hospital and a clinical fellowship in medical oncology at DFCI. He received post-doctoral training at the Whitehead Institute. His research focuses on understanding the molecular and cellular mechanisms underlying the stimulation of antitumor immunity, and on the development of cancer vaccines. Dr. Dranoff is the leader of the Dana-Farber/Harvard Cancer Center Program in Immunology and co-leader of the Dana-Farber Cancer Institute Cancer Vaccine Center. He was elected to the Academy of Cancer Immunology, the American Society of Clinical Investigation, the Osler Interurban Clinical Club, and the Leukemia/Lymphoma Society Stohlman Scholar. He is director of the Human Gene Transfer Laboratory and a staff member of the departments of medical oncology and hematologic neoplasia at Dana-Farber, and is an associate professor of medicine at Harvard Medical School.